Pulse Biosciences, Inc. updated its investor presentation on March 3, 2026, highlighting financial summaries and details about their next-gen cardiac catheter, with a focus on enhanced clinical outcomes from EU studies. The company aims to utilize this information for investor presentations and discussions.